Dolby Laboratories (DLB, Infrastructure software) Stock Valuation & Fair Value
Favorable on our testsDolby Laboratories (DLB, Infrastructure software) trades at a current P/E of 13.0, about 47% below its historical normal valuation, with a forward growth estimate of 9.8% and a PEG of 1.33. Analysts' one-year estimates have been hit 36% of the time. Priced at its historical normal P/E of 24.6 on the same blended earnings, the 2026-11-18 close of $56.83 corresponds to about $107 a share. This is a valuation reference, not a price target. The $56.83 close is the one the P/E is read at; the technical context below uses the 2026-11-18 close, $56.77.
How to read these numbers: the PEG ratio and current P/E versus normal P/E.
- Price $56.77 at the Nov 18 close, 9.8% below the 20-day average ($62.94) and 6.6% below the 50-day ($60.80).
- RSI (14) at 27.9.
- 52-week range $48.23 to $68.26: the price is 16.8% below the high and 17.7% above the low.
The Street vs SeerForecast
Wall Street's mean price target for DLB is $79.00 across 3 analysts, 39.0% above the current price. Our SeerForecast read of the same stock, formed without analyst targets: favorable on our tests. When the two disagree, start your digging there.
Valuation flags
- No notable valuation flags.
Verdict history
tickerseer's rating has been mixed on our tests since 2026-11-14.
Frequently asked questions
Is Dolby Laboratories stock overvalued?
At a current P/E of 13.0 versus its historical normal P/E of 24.6, Dolby Laboratories trades about 47% below its typical valuation, with a PEG of 1.33 on 9.8% forward growth. tickerseer currently rates it favorable on our tests.
What is Dolby Laboratories's fair value and PEG?
Dolby Laboratories trades at a current P/E of 13.0 against a historical normal P/E of 24.6, a PEG of 1.33, and a forward growth estimate of 9.8%. Priced at its historical normal P/E of 24.6 on the same blended earnings, the 2026-11-18 close of $56.83 corresponds to about $107 a share. This is a valuation reference, not a price target.
Has tickerseer's rating of Dolby Laboratories changed?
tickerseer's rating has been mixed on our tests since 2026-11-14.
What is the analyst price target for Dolby Laboratories?
The mean Wall Street price target for Dolby Laboratories is $79.00 across 3 analysts, 39.0% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.
Industry: Infrastructure software. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and an AI research note where we have one. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.